Federal Government Giving Bonuses For A Protocol That Increases The Risk Of Death

"Today, the U.S. Food and Drug Administration took two actions to expand the use of the antiviral drug Veklury to certain non-hospitalized adults and pediatric patients for the treatment of mild-to-moderate COVID-19 disease. This provides another treatment option to reduce the risk of hospitalization in high-risk patients. Previously, the use of Veklury was limited to patients requiring hospitalization."

The administration went on to write, "The FDA has expanded the approved. indication for Veklury to include its use in adults and pediatric patients with positive results of direct SARS-CoV-2 viral testing, and who are not hospitalized and have mild-to-moderate COVID-19, and are at high risk for progression to severe COVID-19, including hospitalization or death."

During a COVID-19 panel held by Republican Senator Ron Johnson, Dr. Paul Marik made some startling accusations not only against the drug remdesivir but the government that is pushing it.

Dr. Marik, who once held a chair of the Division of Pulmonary and Critical Care Medicine at Eastern Virginia Medical School, claimed that the drug remdesivir increased the risk of death by three percent and renal failure by a whopping 20%. Still, as mentioned above, the drug is being approved by the FDA. Not only that, but Dr. Marik added that hospitals are receiving a 20% bonus from the federal government if they prescribe remdesivir to Medicare patients.

 https://www.redvoicemedia.com/2022/01/federal-government-giving-bonuses-for-a-protocol-that-increases-the-risk-of-death-dr-paul-marik-video/